TetraLogic Pharmaceuticals Pink Sheet Forecast - Polynomial Regression
The Polynomial Regression forecasted value of TetraLogic Pharmaceuticals Corp on the next trading day is expected to be 0.000074 with a mean absolute deviation of 0.00000482 and the sum of the absolute errors of 0.0003. TetraLogic Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of TetraLogic Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of TetraLogic Pharmaceuticals' share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using TetraLogic Pharmaceuticals hype-based prediction, you can estimate the value of TetraLogic Pharmaceuticals Corp from the perspective of TetraLogic Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of TetraLogic Pharmaceuticals Corp on the next trading day is expected to be 0.000074 with a mean absolute deviation of 0.00000482 and the sum of the absolute errors of 0.0003. TetraLogic Pharmaceuticals after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TetraLogic |
TetraLogic Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine TetraLogic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TetraLogic using various technical indicators. When you analyze TetraLogic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
TetraLogic Pharmaceuticals Polynomial Regression Price Forecast For the 24th of January
Given 90 days horizon, the Polynomial Regression forecasted value of TetraLogic Pharmaceuticals Corp on the next trading day is expected to be 0.000074 with a mean absolute deviation of 0.00000482, mean absolute percentage error of 0, and the sum of the absolute errors of 0.0003.Please note that although there have been many attempts to predict TetraLogic Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that TetraLogic Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
TetraLogic Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest TetraLogic Pharmaceuticals | TetraLogic Pharmaceuticals Price Prediction | Buy or Sell Advice |
TetraLogic Pharmaceuticals Forecasted Value
In the context of forecasting TetraLogic Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. TetraLogic Pharmaceuticals' downside and upside margins for the forecasting period are 0.00 and 12.91, respectively. We have considered TetraLogic Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of TetraLogic Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent TetraLogic Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 95.3143 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 9.223372036854776E14 |
| SAE | Sum of the absolute errors | 3.0E-4 |
Predictive Modules for TetraLogic Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TetraLogic Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.TetraLogic Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of TetraLogic Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TetraLogic Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of TetraLogic Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TetraLogic Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting TetraLogic Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TetraLogic Pharmaceuticals' historical news coverage. TetraLogic Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 12.91, respectively. We have considered TetraLogic Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TetraLogic Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of TetraLogic Pharmaceuticals is based on 3 months time horizon.
TetraLogic Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as TetraLogic Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TetraLogic Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TetraLogic Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.67 | 12.91 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
TetraLogic Pharmaceuticals Hype Timeline
TetraLogic Pharmaceuticals is at this time traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. TetraLogic is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -1.67%. %. The volatility of related hype on TetraLogic Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.4. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TetraLogic Pharmaceuticals recorded a loss per share of 1.65. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out Historical Fundamental Analysis of TetraLogic Pharmaceuticals to cross-verify your projections.TetraLogic Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to TetraLogic Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict TetraLogic Pharmaceuticals' future price movements. Getting to know how TetraLogic Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TetraLogic Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ARNI | Arno Therapeutics | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 100.00 | |
| CALA | Calithera Biosciences | 0.00 | 0 per month | 20.36 | 0.18 | 100.00 | (50.00) | 480.00 | |
| ONPH | Oncology Pharma | 0.00 | 0 per month | 28.91 | 0.20 | 200.00 | (66.67) | 1,995 | |
| PANC | Panacos Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IVBT | Innovation1 Biotech | 0.00 | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BXRXQ | Baudax Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KLDO | Kaleido Biosciences | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 4,998 | |
| TNGNQ | Tengion | 0.00 | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AMPE | Ampio Pharm | 0.00 | 1 per month | 51.23 | 0.33 | 3,974 | (96.30) | 9,998 |
Other Forecasting Options for TetraLogic Pharmaceuticals
For every potential investor in TetraLogic, whether a beginner or expert, TetraLogic Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. TetraLogic Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in TetraLogic. Basic forecasting techniques help filter out the noise by identifying TetraLogic Pharmaceuticals' price trends.TetraLogic Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TetraLogic Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of TetraLogic Pharmaceuticals could also be used in its relative valuation, which is a method of valuing TetraLogic Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Story Coverage note for TetraLogic Pharmaceuticals
The number of cover stories for TetraLogic Pharmaceuticals depends on current market conditions and TetraLogic Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TetraLogic Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TetraLogic Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
TetraLogic Pharmaceuticals Short Properties
TetraLogic Pharmaceuticals' future price predictability will typically decrease when TetraLogic Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TetraLogic Pharmaceuticals Corp often depends not only on the future outlook of the potential TetraLogic Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TetraLogic Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.7 M | |
| Cash And Short Term Investments | 20.4 M |
Other Information on Investing in TetraLogic Pink Sheet
TetraLogic Pharmaceuticals financial ratios help investors to determine whether TetraLogic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TetraLogic with respect to the benefits of owning TetraLogic Pharmaceuticals security.